Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
Virchows Archiv : an International Journal of Pathology|July 15, 2020
Epithelial-mesenchymal transition in undifferentiated carcinoma of the pancreas with and without osteoclast-like giant cellsPaola Mattiolo, Giulia Fiadone, Gaetano Paolino, et al.
Cancers|June 28, 2023
Comparative Analyses of the Clinicopathologic Features of Short-Term and Long-Term Survivors of Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and PancreatoduodenectomyTom Z Liang, Matthew H G Katz, Laura R Prakash, et al.
Gut|May 1, 2020
Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implicationsClaudio Luchini, Lodewijk A A Brosens, Laura D Wood, et al.
Annals of Surgical Oncology|October 30, 2014
Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic cancerChristina L Roland, Anthony D Yang, Matthew H G Katz, et al.
The American Journal of Surgical Pathology|February 4, 2012
Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinomaDeyali Chatterjee, Matthew H Katz, Asif Rashid, et al.
Cancer|October 27, 2011
Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma: a predictor for patient outcomeDeyali Chatterjee, Matthew H Katz, Asif Rashid, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2023
Integrated Genomic and Clinicopathologic Approach Distinguishes Pancreatic Grade 3 Neuroendocrine Tumor From Neuroendocrine Carcinoma and Identifies a Subset With Molecular OverlapSarah E Umetsu, Sanjay Kakar, Olca Basturk, et al.
Cancers|October 16, 2024
The Association between Sampling and Survival in Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and PancreaticoduodenectomyMehran Taherian, Matthew H G Katz, Laura R Prakash, et al.
Cancers|May 13, 2023
Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy and PancreatectomyYi Tat Tong, Zongshan Lai, Matthew H G Katz, et al.
The American Journal of Surgical Pathology|July 1, 2024
Tubulocystic Carcinoma of Bile Ducts: A Distinct Type of Cholangiocarcinoma Associated With Adenofibroma-type LesionsFrancesca Masetto, Andrea Mafficini, Burcu Saka, et al.
Pageof 10